What does PHARMACIE GOFFIN do?

PHARMACIE GOFFIN is a pharmacy in Profondeville. Private Limited, started on 15 January 2002, 1 establishment.

What is the address of PHARMACIE GOFFIN?

The registered office of PHARMACIE GOFFIN is located at Rue E. Falmagne(LU) 7, 5170 Profondeville.

Is PHARMACIE GOFFIN still active?

Yes. According to the CBE (29 October 2026) PHARMACIE GOFFIN is active, legal situation “Normale toestand”, started on 15 January 2002.

Is PHARMACIE GOFFIN registered on Peppol?

Yes, PHARMACIE GOFFIN is registered on the Peppol network with ID 0208:0476440739.

What is the enterprise number of PHARMACIE GOFFIN?

The enterprise number of PHARMACIE GOFFIN is BE0476440739.

When was PHARMACIE GOFFIN founded?

PHARMACIE GOFFIN was founded on 15 January 2002.

Who are the directors of PHARMACIE GOFFIN?

According to the 2025 annual accounts, the directors of PHARMACIE GOFFIN are: André Goffin.

Is PHARMACIE GOFFIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 January 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE GOFFIN make in 2025?

PHARMACIE GOFFIN posted a profit after taxes of € 9,624 in financial year 2025.

What is the revenue of PHARMACIE GOFFIN?

As a small company, PHARMACIE GOFFIN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 77,875.

How many employees does PHARMACIE GOFFIN have?

According to the 2025 annual accounts, PHARMACIE GOFFIN has 0.3 full-time equivalents (FTE).

PHARMACIE GOFFIN (Private Limited) - Profondeville

Dossier PHARMACIE GOFFIN, printed on 29 October 2026 from databakkes.be/en/0476440739/pharmacie-goffin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 49 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE GOFFIN from Profondeville, company number BE0476440739, closed financial year 2025 with a result of € 9,624 after tax. For that financial year PHARMACIE GOFFIN recorded a gross margin of € 77,875 and equity of € 72,425. Compared with financial year 2024, the result moved from € 2,252 to € 9,624. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.

What it is worth Growing

€ 72,425

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 9,624

▲ € 7,372 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 16,681

▲ 63% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 53,825.

People and assets in 2025

Full-time equivalents

0.3

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 5,868

▼ 2% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 36,240

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 169,581

▼ 17% vs 2024

€ 36,920 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 123,782

▲ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,604

▲ 1% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 87,103 Gross margin 2022: € 87,103 First fiscal year in the series	€ 74,215 Gross margin 2023: € 74,215 ▼ 15% vs 2022 (€ 87,103) Unfavourable step	€ 63,575 Gross margin 2024: € 63,575 ▼ 14% vs 2023 (€ 74,215) Unfavourable step	€ 77,875 Gross margin 2025: € 77,875 ▲ 22% vs 2024 (€ 63,575) Favourable step	▲ 22%
Profit after taxes	€ 21,536 Profit after taxes 2022: € 21,536 First fiscal year in the series	€ 14,353 Profit after taxes 2023: € 14,353 ▼ 33% vs 2022 (€ 21,536) Unfavourable step	€ 2,252 Profit after taxes 2024: € 2,252 ▼ 84% vs 2023 (€ 14,353) Unfavourable step	€ 9,624 Profit after taxes 2025: € 9,624 ▲ € 7,372 vs 2024 (€ 2,252) Favourable step	▲ € 7,372
Equity	€ 47,855 Equity 2022: € 47,855 First fiscal year in the series	€ 61,408 Equity 2023: € 61,408 ▲ 28% vs 2022 (€ 47,855) Favourable step	€ 62,801 Equity 2024: € 62,801 ▲ 2% vs 2023 (€ 61,408) Favourable step	€ 72,425 Equity 2025: € 72,425 ▲ 15% vs 2024 (€ 62,801) Favourable step	▲ 15%
Total debts	€ 405,223 Total debts 2022: € 405,223 First fiscal year in the series	€ 369,405 Total debts 2023: € 369,405 ▼ 9% vs 2022 (€ 405,223) Favourable step	€ 336,163 Total debts 2024: € 336,163 ▼ 9% vs 2023 (€ 369,405) Favourable step	€ 307,967 Total debts 2025: € 307,967 ▼ 8% vs 2024 (€ 336,163) Favourable step	▼ 8%
Cash	€ 40,162 Cash 2022: € 40,162 First fiscal year in the series	€ 35,802 Cash 2023: € 35,802 ▼ 11% vs 2022 (€ 40,162) Unfavourable step	€ 10,235 Cash 2024: € 10,235 ▼ 71% vs 2023 (€ 35,802) Unfavourable step	€ 16,681 Cash 2025: € 16,681 ▲ 63% vs 2024 (€ 10,235) Favourable step	▲ 63%
Land & buildings	€ 226,073 Land & buildings 2022: € 226,073 First fiscal year in the series	€ 207,592 Land & buildings 2023: € 207,592 ▼ 8% vs 2022 (€ 226,073) Unchanged	€ 184,310 Land & buildings 2024: € 184,310 ▼ 11% vs 2023 (€ 207,592) Unchanged	€ 157,927 Land & buildings 2025: € 157,927 ▼ 14% vs 2024 (€ 184,310) Unchanged	▼ 14%
Retained profit	€ 29,255 Retained profit 2022: € 29,255 First fiscal year in the series	€ 42,808 Retained profit 2023: € 42,808 ▲ 46% vs 2022 (€ 29,255) Favourable step	€ 44,201 Retained profit 2024: € 44,201 ▲ 3% vs 2023 (€ 42,808) Favourable step	€ 53,825 Retained profit 2025: € 53,825 ▲ 22% vs 2024 (€ 44,201) Favourable step	▲ 22%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 800) Unchanged	€ 859 Dividend 2024: € 859 ▲ 7% vs 2023 (€ 800) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 859) Unchanged	▼ 100%
Bank debt	€ 244,496 Bank debt 2022: € 244,496 First fiscal year in the series	€ 211,867 Bank debt 2023: € 211,867 ▼ 13% vs 2022 (€ 244,496) Favourable step	€ 205,097 Bank debt 2024: € 205,097 ▼ 3% vs 2023 (€ 211,867) Favourable step	€ 169,581 Bank debt 2025: € 169,581 ▼ 17% vs 2024 (€ 205,097) Favourable step	▼ 17%
Balance sheet total	€ 453,078 Balance sheet total 2022: € 453,078 First fiscal year in the series	€ 430,813 Balance sheet total 2023: € 430,813 ▼ 5% vs 2022 (€ 453,078) Unchanged	€ 398,964 Balance sheet total 2024: € 398,964 ▼ 7% vs 2023 (€ 430,813) Unchanged	€ 380,392 Balance sheet total 2025: € 380,392 ▼ 5% vs 2024 (€ 398,964) Unchanged	▼ 5%
Employees (FTE)	0.2 Employees (FTE) 2022: 0.2 First fiscal year in the series	0.2 Employees (FTE) 2023: 0.2 Unchanged (0.2) Unchanged	0.2 Employees (FTE) 2024: 0.2 Unchanged (0.2) Unchanged	0.3 Employees (FTE) 2025: 0.3 ▲ 0.1 vs 2024 (0.2) Unchanged	▲ 0.1

Key figures of PHARMACIE GOFFIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE GOFFIN?

What happened at PHARMACIE GOFFIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 12, 2026 New annual accounts for financial year 2025: profit of € 9,624 (▲ € 7,372 vs 2024). Source: NBB ↗
Mar 7, 2002 New establishment in Profondeville. KBO
Jan 15, 2002 Start of the company according to the CBE. KBO
2001 André Goffin became a director. NBB

In short

From € 21,536 profit in 2022 to € 9,624 profit in 2025.

Paid € 29,427 in corporate taxes since 2022.

Best year ever: 2022, with € 21,536 profit.

Paid out € 2,459 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

André Goffin

PHARMACIE GOFFIN

Behind PHARMACIE GOFFIN is André Goffin.

Directors

According to the 2025 annual accounts

André Goffin

Director

since 2001

Establishments

Establishment units

Physical locations of this company

Registered office

Rue E. Falmagne(LU) 7

5170 Profondeville

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

G Fin

€ 22,306 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0476.440.739

VAT number

BE 0476.440.739

Registered office

Rue E. Falmagne(LU) 7, 5170 Profondeville

Names & denominations

PHARMACIE GOFFIN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

15 January 2002

Peppol

Active · Active since 18 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE GOFFIN

Warning lights

Financials

What happened to PHARMACIE GOFFIN?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions